Preneoplastic lesions as end points in carcinogenicity testing. I. Hepatic preneoplasia.
Bannasch
P
P
D000818:Animals; D002273:Carcinogens; D002455:Cell Division; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D008099:Liver / Q000201:enzymology / Q000473:pathology; D008112:Liver Glycogen / Q000032:analysis; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced*; D051379:Mice; D010641:Phenotype; D011230:Precancerous Conditions / Q000139:chemically induced*; D051381:Rats; D005723:gamma-Glutamyltransferase / Q000032:analysis
D002273:Carcinogens; D008112:Liver Glycogen; D005723:gamma-Glutamyltransferase